Rats selectively bred for high saccharin intake (HiS) self-administer more cocaine, escalate their cocaine intake during long access, and reinstate cocaine seeking at higher levels than those bred for low saccharin intake (LoS). The present study was conducted to determine if baclofen, an agonist at the GABA b receptor, has differential effects on the escalation of i.v. cocaine intake and reinstatement of cocaine-seeking in HiS and LoS rats. HiS and LoS rats self-administered cocaine during a 2-h daily short-access (ShA) phase for 3 days and then long-access (LgA) sessions for 21 days followed by a second ShA phase. One group of HiS and LoS rats received i.p. injections of 2.5 mg/kg baclofen (HiS + B and LoS + B, respectively), and other groups of HiS and LoS rats received saline (HiS + Sal and LoS + Sal) before each daily session. In a second experiment, HiS and LoS rats self-administered i.v. cocaine during 2-h sessions for 14 days followed by a 21-day extinction period. Baclofen (2.5 mg/kg, i.p.) or saline was administered before saline- or cocaine-primed reinstatement sessions. The HiS + B group escalated their cocaine self-administration and had increased cocaine infusions in the post-LgA ShA phase. The LoS + B group self-administered less cocaine throughout the entire LgA period compared to the LoS + Sal or HiS groups. Baclofen attenuated reinstatement of cocaine seeking in both the HiS and LoS rats with no phenotype differences. Thus, baclofen had opposite effects on cocaine intake in HiS and LoS rats during escalation; but similar effects during reinstatement. These results suggest that treatment effects might vary with individual differences (HiS vs. LoS) and the phase of drug-motivated behavior that is modeled.
|Original language||English (US)|
|Number of pages||9|
|Journal||Pharmacology Biochemistry and Behavior|
|State||Published - Dec 2011|
Bibliographical noteFunding Information:
This research was supported by NIDA/NIH grants R01 DA024196 , DA003240 , and K05 DA015267 (MEC). We thank Dr. Justin Anker, Paul Regier, and Natalie Zlebnik for their assistance with the preparation of this manuscript and Luke Gliddon, Amy Saykao, Rachael Turner and Troy Velie for their technical assistance.
- Saccharin preference